Matthias Schlesner
- Cancer Research top 1%
- Cancer Genomics and Diagnostics 16
- Molecular Biology top 1%
- Bioinformatics and Genomic Networks 10
- Epigenetics and DNA Methylation 9
- Single-cell and spatial transcriptomics 8
- Gene expression and cancer classification 8
- Immunology top 2%
- Oncology top 2%
- Genetics top 2%
- Genomics and Rare Diseases 9
- Glioma Diagnosis and Treatment 9
-
- Genetic factors in colorectal cancer 11
Matthias Schlesner
87 papers receiving 9.7k citations
Hit Papers
Peers
Comparison fields: 5 of 206
- Cancer Research 1.3k
- Molecular Biology 4.8k
- Immunology 1.3k
- Oncology 1.3k
- Genetics 401
Countries citing papers authored by Matthias Schlesner
This map shows the geographic impact of Matthias Schlesner's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Matthias Schlesner with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Matthias Schlesner more than expected).
Fields of papers citing papers by Matthias Schlesner
This network shows the impact of papers produced by Matthias Schlesner. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Matthias Schlesner. The network helps show where Matthias Schlesner may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Matthias Schlesner, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 0 | |
| 2 | 2024 | 26 | |
| 3 | 2024 | 1 | |
| 4 | 2024 | 1 | |
| 5 | 2024 | 0 | |
| 6 | 2024 | 0 | |
| 7 | 2023 | 30 | |
| 8 | 2022 | 7 | |
| 9 | 2022 | 5 | |
| 10 | 2021 | 1 | |
| 11 | 2021 | 75 | |
| 12 | 2021 | 0 | |
| 13 | 2020 | 21 | |
| 14 | 2020 | 9 | |
| 15 | 2020 | 4 | |
| 16 | 2019 | 6 | |
| 17 | 2019 | 17 | |
| 18 | 2019 | 14 | |
| 19 | 2016 | 62 | |
| 20 | 2015 | 14 |
About Matthias Schlesner
Matthias Schlesner is a scholar working on Cancer Research, Genetics and Pathology and Forensic Medicine, having authored 94 papers that have together received 9.7k indexed citations. Recurring topics across this work include Cancer Genomics and Diagnostics (16 papers), Genetic factors in colorectal cancer (11 papers), Bioinformatics and Genomic Networks (10 papers), Genomics and Rare Diseases (9 papers), Glioma Diagnosis and Treatment (9 papers), Epigenetics and DNA Methylation (9 papers), Single-cell and spatial transcriptomics (8 papers) and Gene expression and cancer classification (8 papers). The work is most often cited by research in Cancer Research (1.3k citations), Molecular Biology (4.8k citations) and Immunology (1.3k citations). Matthias Schlesner has collaborated with scholars based in Germany, United States and Czechia. Frequent co-authors include Roland Eils, Zuguang Gu, Benedikt Brors, Lei Gu, Naveed Ishaque, Bjoern Titz, Peter Uetz, Nagarajan Paramasivam, Reiner Siebert and Stefan Wiemann. Their work appears in journals such as Nucleic Acids Research, Nature Communications and Journal of Clinical Oncology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.